cagrilintide vs retatrutide vs tirzepatide vs. Tirzepatide: The New Contender vs. the Current Leader 🧬 Peptide Spotlight: Tirzepatide vs. – Cagrilintide vs Tirzepatide Compared Retatrutide + Cagrilintide: The Weight

In addition, in recent times, several people have advocated for the inclusion of unwelcome weight gain on the list of potential adverse effects

In contrast, the difference in liver fibrosis resolution stage did not reach statistical significance (liver fibrosis staging improved in 43% of participants in the semaglutide arm vs 33% in the placebo arm), potentially owing to a lack of power within the study or the relatively short follow-up time of 72 weeks

Distinguishing between expected, manageable side effects and potentially serious complications is essential for patient safety

Saez E, Rosenfeld J, Livolsi A, Olson P, Lombardo E, Nelson M, et al